4YB Analyst Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4YB Stock 12 Month Forecast
Average Price Target
$42.04
| Highest Price Target$57.80 | Average Price Target$42.04 | Lowest Price Target$26.27 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
LifeSci Capital
€46.42
Buy
―
Assigned
07/11/26
Citi
€49.92→€53.42
Buy
―
Reiterated
06/30/26
Piper Sandler
€57.8
Buy
―
Reiterated
05/29/26
Guggenheim
€38.54→€54.3
Buy
―
Reiterated
05/26/26
H.C. Wainwright
€35.03
Buy
―
Reiterated
05/26/26
J.P. Morgan
€30.65→€41.16
Buy
―
Reiterated
05/26/26
Stifel Nicolaus
€42.91
Buy
―
Reiterated
05/25/26
Truist Financial
€20.14→€26.27
Hold
―
Reiterated
05/22/26
Wells Fargo
€39.41
Buy
―
Reiterated
05/21/26
Bank of America Securities
€28.03→€37.66
Buy
―
Reiterated
05/21/26
Goldman Sachs
€25.4→€28.03
Hold
―
Assigned
04/15/26
Wolfe Research
€41.16
Buy
―
Reiterated
04/06/26
Leerink Partners
€45.54→€43.79
Buy
―
Reiterated
04/02/26
Bernstein
€24.52
Hold
―
Initiated
03/20/26
Oppenheimer
€47.29
Buy
―
Reiterated
02/09/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
€46.42
Buy
―
Assigned
07/11/26
Citi
€49.92→€53.42
Buy
―
Reiterated
06/30/26
Piper Sandler
€57.8
Buy
―
Reiterated
05/29/26
Guggenheim
€38.54→€54.3
Buy
―
Reiterated
05/26/26
H.C. Wainwright
€35.03
Buy
―
Reiterated
05/26/26
J.P. Morgan
€30.65→€41.16
Buy
―
Reiterated
05/26/26
Stifel Nicolaus
€42.91
Buy
―
Reiterated
05/25/26
Truist Financial
€20.14→€26.27
Hold
―
Reiterated
05/22/26
Wells Fargo
€39.41
Buy
―
Reiterated
05/21/26
Bank of America Securities
€28.03→€37.66
Buy
―
Reiterated
05/21/26
Goldman Sachs
€25.4→€28.03
Hold
―
Assigned
04/15/26
Wolfe Research
€41.16
Buy
―
Reiterated
04/06/26
Leerink Partners
€45.54→€43.79
Buy
―
Reiterated
04/02/26
Bernstein
€24.52
Hold
―
Initiated
03/20/26
Oppenheimer
€47.29
Buy
―
Reiterated
02/09/26
Best Analysts Covering Immunovant
3 Months
Success Rate
12/20 ratings generated profit
Average Return
+24.16%
Copying Thomas Smith's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +24.16% per trade.
1 Year
Success Rate
12/20 ratings generated profit
Average Return
+70.34%
Copying Thomas Smith's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +70.34% per trade.
2 Years
Success Rate
15/20 ratings generated profit
Average Return
+102.55%
Copying Thomas Smith's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +102.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4YB Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
4
12
10
11
3
Buy
5
4
8
8
9
Hold
3
3
3
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
19
21
21
13
Each month's total comprises the sum of three months' worth of ratings.
4YB Financial Forecast
4YB Stock Forecast FAQ
What is DE:4YB’s average 12-month price target, according to analysts?
Based on analyst ratings, Immunovant, Inc.’s 12-month average price target is 42.04.
What is DE:4YB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:4YB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Immunovant, Inc. a Buy, Sell or Hold?
Immunovant, Inc. has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is Immunovant, Inc.’s share price target?
The average share price target for Immunovant, Inc. is 42.04. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $57.80 ,and the lowest forecast is $26.27. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is $57.80 ,and the lowest forecast is $26.27. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Immunovant, Inc.?
Immunovant, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of Immunovant, Inc.?
To buy shares of DE:4YB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.